Relative Contributions of Marrow Microenvironment, Growth Factors, and Stem Cells to Hematopoiesis in Vivo in Man
- 17 December 1995
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 770 (1) , 315-338
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.Journal of Clinical Oncology, 1995
- Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activity.Journal of Clinical Oncology, 1994
- Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a Phase I/II study in breast cancer patientsSurgical Oncology, 1993
- Ifosfamide, carboplatin, and etoposide in combination for induction and high‐dose chemotherapy: focus on breast cancer and lymphomaHematological Oncology, 1992
- Myeloablative chemoradiotherapy and autologous bone marrow infusions for treatment of neuroblastoma: factors influencing engraftmentBlood, 1991
- Marrow Transplantation in Acute Leukemia Following Busulfan and Cyclophosphamide1980